Primary progressive multiple sclerosis
RecruitingOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
- Disease:Primary progressive multiple sclerosis
- Substances:–
Romania- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Romania116 clinical trials in Targu Mures, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on cardiovascular conditions and blood disorders, including groundbreaking trials for hypertension management and rare blood conditions.
Novel treatments being evaluated to improve patient outcomes in resistant hypertension and blood disorders.
Innovative research in blood cancers and lymphomas, exploring new therapeutic approaches for various forms of leukemia and lymphoma.
Evaluating combination therapies and targeted treatments for better cancer care outcomes.
Research focused on managing chronic diseases, including innovative approaches to kidney disease, diabetes, and respiratory conditions.
Studies aim to improve quality of life and disease management for patients with chronic conditions.
Advanced research in neurological conditions, investigating new treatments for epilepsy and multiple sclerosis.
Evaluating innovative therapeutic approaches for better neurological disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.